Literature DB >> 17415511

Transcranial ultrasound in different monogenetic subtypes of Parkinson's disease.

Katherine J Schweitzer1, Theresa Brüssel, Petra Leitner, Rejko Krüger, Peter Bauer, Dirk Woitalla, Jürgen Tomiuk, Thomas Gasser, Daniela Berg.   

Abstract

Hyperechogenicity of the substantia nigra (SN) has been found to be a typical sign in idiopathic Parkinson's disease (PD), prevalent in more than 90% of affected individuals. To see whether SN hyperechogenicity is also characteristic for monogenetically caused PD, we investigated PD patients with alpha-synuclein, LRRK2, parkin, PINK1 and DJ-1 mutations by transcranial sonography (TCS). In all these patients the area of SN echogenicity was significantly larger than in healthy controls, but smaller, than in idiopathic PD. As SN hyperechogenicity could be related to an increased iron content of the SN, these findings suggest that iron may play a less significant role in the pathogenesis of monogenetically caused compared to idiopathic PD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17415511     DOI: 10.1007/s00415-006-0369-7

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  19 in total

1.  Blood-brain barrier dysfunction in parkinsonian midbrain in vivo.

Authors:  Rudie Kortekaas; Klaus L Leenders; Joost C H van Oostrom; Willem Vaalburg; Joost Bart; Antoon T M Willemsen; N Harry Hendrikse
Journal:  Ann Neurol       Date:  2005-02       Impact factor: 10.422

2.  Brain parenchyma sonography detects preclinical parkinsonism.

Authors:  Uwe Walter; Christine Klein; Ruediger Hilker; Reiner Benecke; Peter P Pramstaller; Dirk Dressler
Journal:  Mov Disord       Date:  2004-12       Impact factor: 10.338

3.  Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function.

Authors:  Cheng Wang; Han Seok Ko; Bobby Thomas; Fai Tsang; Katherine C M Chew; Shiam-Peng Tay; Michelle W L Ho; Tit-Meng Lim; Tuck-Wah Soong; Olga Pletnikova; Juan Troncoso; Valina L Dawson; Ted M Dawson; Kah-Leong Lim
Journal:  Hum Mol Genet       Date:  2005-11-08       Impact factor: 6.150

4.  Implications of alterations in trace element levels in brain in Parkinson's disease and other neurological disorders affecting the basal ganglia.

Authors:  D T Dexter; J Sian; P Jenner; C D Marsden
Journal:  Adv Neurol       Date:  1993

5.  Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings.

Authors:  D Berg; C Siefker; G Becker
Journal:  J Neurol       Date:  2001-08       Impact factor: 4.849

6.  In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage.

Authors:  Luigi Zecca; Daniela Berg; Thomas Arzberger; Petra Ruprecht; Wolf D Rausch; Massimo Musicco; Davide Tampellini; Peter Riederer; Manfred Gerlach; Georg Becker
Journal:  Mov Disord       Date:  2005-10       Impact factor: 10.338

7.  Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease.

Authors:  Daniela Berg; Berthold Merz; Karlheinz Reiners; Markus Naumann; Georg Becker
Journal:  Mov Disord       Date:  2005-03       Impact factor: 10.338

Review 8.  Transgenic models of alpha-synuclein pathology: past, present, and future.

Authors:  Makoto Hashimoto; Edward Rockenstein; Eliezer Masliah
Journal:  Ann N Y Acad Sci       Date:  2003-06       Impact factor: 5.691

9.  Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury.

Authors:  Daniela Berg; Wolfgang Roggendorf; Ute Schröder; Rüdiger Klein; Thomas Tatschner; Peter Benz; Oliver Tucha; Michael Preier; Klaus W Lange; Karlheinz Reiners; Manfred Gerlach; Georg Becker
Journal:  Arch Neurol       Date:  2002-06

10.  Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes.

Authors:  V Bonifati; C F Rohé; G J Breedveld; E Fabrizio; M De Mari; C Tassorelli; A Tavella; R Marconi; D J Nicholl; H F Chien; E Fincati; G Abbruzzese; P Marini; A De Gaetano; M W Horstink; J A Maat-Kievit; C Sampaio; A Antonini; F Stocchi; P Montagna; V Toni; M Guidi; A Dalla Libera; M Tinazzi; F De Pandis; G Fabbrini; S Goldwurm; A de Klein; E Barbosa; L Lopiano; E Martignoni; P Lamberti; N Vanacore; G Meco; B A Oostra
Journal:  Neurology       Date:  2005-07-12       Impact factor: 9.910

View more
  14 in total

1.  Substantia nigra hyperechogenicity with LRRK2 G2019S mutations.

Authors:  Norbert Brüggemann; Johann Hagenah; Kaili Stanley; Christine Klein; Cuiling Wang; Deborah Raymond; Laurie Ozelius; Susan Bressman; Rachel Saunders-Pullman
Journal:  Mov Disord       Date:  2011-02-10       Impact factor: 10.338

Review 2.  Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: yes.

Authors:  Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2011-01-05       Impact factor: 3.575

3.  Detection of MPTP-induced substantia nigra hyperechogenicity in Rhesus monkeys by transcranial ultrasound.

Authors:  Thyagarajan Subramanian; Christopher A Lieu; Kumaraswamy Guttalu; Daniela Berg
Journal:  Ultrasound Med Biol       Date:  2010-03-07       Impact factor: 2.998

Review 4.  Hyperechogenicity of the substantia nigra: pitfalls in assessment and specificity for Parkinson's disease.

Authors:  Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2010-09-10       Impact factor: 3.575

Review 5.  [Sonography of the parenchyma in Parkinson's disease].

Authors:  J Hagenah; G Seidel
Journal:  Nervenarzt       Date:  2010-10       Impact factor: 1.214

Review 6.  Brain Iron Metabolism Dysfunction in Parkinson's Disease.

Authors:  Hong Jiang; Jun Wang; Jack Rogers; Junxia Xie
Journal:  Mol Neurobiol       Date:  2016-04-02       Impact factor: 5.590

7.  The predictive power of transcranial sonography in movement disorders: a longitudinal cohort study.

Authors:  Daniela Monaco; Daniela Berg; Astrid Thomas; Vincenzo Di Stefano; Filomena Barbone; Michela Vitale; Camilla Ferrante; Laura Bonanni; Marta Di Nicola; Tonia Garzarella; Luciano Paolo Marchionno; Giovanni Malferrari; Rocco Di Mascio; Marco Onofrj; Raffaella Franciotti
Journal:  Neurol Sci       Date:  2018-08-07       Impact factor: 3.307

8.  Major Alterations of Phosphatidylcholine and Lysophosphotidylcholine Lipids in the Substantia Nigra Using an Early Stage Model of Parkinson's Disease.

Authors:  Kyle Farmer; Catherine A Smith; Shawn Hayley; Jeffrey Smith
Journal:  Int J Mol Sci       Date:  2015-08-12       Impact factor: 5.923

9.  A Brief Nonmotor Screen Combined with Transcranial Ultrasound may Improve Diagnostic Accuracy of Parkinson's Disease.

Authors:  Michael Hayes; Peter Puhl; Johann Hagenah; Robert Russo
Journal:  Mov Disord Clin Pract       Date:  2016-11-01

Review 10.  Nigral iron elevation is an invariable feature of Parkinson's disease and is a sufficient cause of neurodegeneration.

Authors:  Scott Ayton; Peng Lei
Journal:  Biomed Res Int       Date:  2014-01-16       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.